• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗磷脂综合征分类的 1999 年札幌标准和 2006 年修订标准的比较。

Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome.

机构信息

Department of Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.

出版信息

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):914-9.

PMID:20149305
Abstract

OBJECTIVES

The 2006 revised criteria for antiphospholipid syndrome (APS) provide a new classification challenge, and studies validating the updated criteria against the older ones are still scanty. We compared the 1999 preliminary with the 2006 revised classification criteria for APS, and evaluated if the revised criteria provide an added value over the original ones.

METHODS

A laboratory-based registry population was obtained on the basis of the positivity of antiphospholipid (aPL) antibodies. Patients were analysed for fulfillment of the 1999 and 2006 classification criteria for APS, non-criteria features of APS, and autoantibody profile.

RESULTS

Of 144 aPL-positive identified patients, 119 had at least 2 aPL tests on separated occasions, and were included in this study. According to the 1999 criteria, 23 patients had APS (15 had thrombosis alone, 4 pregnancy morbidity, and 4 both); while 26 fulfilled the 2006 revised criteria (15 had thrombosis alone, 5 pregnancy morbidity, and 6 both). One patient with isolated thrombosis who met 1999 criteria did not meet those of 2006 (aCL positivity but not >12 weeks apart). One patient with thrombosis, other with pregnancy morbidity, and 2 with both only fulfilled the 2006 criteria because they had isolated anti-Beta(2)GPI antibody-positivity. High concordance between criteria was found, with kappa index of 0.87 (95%; CI, 0.76-0.98).

CONCLUSIONS

The 2006 revised criteria represent a step-forward since it allows the inclusion of patients with anti-Beta(2)GPI antibodies as an isolated serological feature. However, a wider time interval between serologic tests seems unlikely to make differences.

摘要

目的

2006 年修订的抗磷脂综合征(APS)标准提出了新的分类挑战,而验证这些更新标准的研究仍然很少。我们比较了 1999 年初步标准和 2006 年修订标准,评估了修订标准是否比原始标准更有价值。

方法

根据抗磷脂(aPL)抗体的阳性结果,我们获得了一个基于实验室的登记人群。对患者进行了 1999 年和 2006 年 APS 分类标准、APS 的非标准特征和自身抗体谱的分析。

结果

在 144 名 aPL 阳性的患者中,有 119 名患者至少有 2 次相隔时间的 aPL 检测,他们被纳入本研究。根据 1999 年标准,有 23 名患者患有 APS(15 名有血栓形成,4 名有妊娠并发症,4 名两者都有);而 26 名患者符合 2006 年修订标准(15 名有血栓形成,5 名有妊娠并发症,6 名两者都有)。一名仅符合 1999 年标准的孤立性血栓形成患者不符合 2006 年标准(aCL 阳性,但两次检测时间间隔不足 12 周)。一名有血栓形成、另一名有妊娠并发症、2 名有两者的患者仅符合 2006 年标准,因为他们仅具有孤立的抗β2-GPI 抗体阳性。标准之间的一致性很高,kappa 指数为 0.87(95%可信区间,0.76-0.98)。

结论

2006 年修订标准是一个进步,因为它允许将具有抗β2-GPI 抗体的患者作为一种孤立的血清学特征纳入。然而,两次血清学检测之间更长的时间间隔似乎不太可能产生差异。

相似文献

1
Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome.抗磷脂综合征分类的 1999 年札幌标准和 2006 年修订标准的比较。
Clin Exp Rheumatol. 2009 Nov-Dec;27(6):914-9.
2
Assessment of the 2006 revised antiphospholipid syndrome classification criteria.2006年修订的抗磷脂综合征分类标准评估
Ann Rheum Dis. 2007 Jul;66(7):927-30. doi: 10.1136/ard.2006.067314. Epub 2007 Mar 2.
3
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.通过检测 IgG 抗体针对β2-糖蛋白 I 结构域 1 和结构域 4/5 对抗磷脂综合征进行临床特征分析:抗结构域 1 与抗结构域 4/5 的比值作为抗磷脂综合征的一种有用的新型生物标志物。
Arthritis Rheumatol. 2015 May;67(8):2196-204. doi: 10.1002/art.39187.
4
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.根据 Sapporo 修订分类标准,有或无明确原发性抗磷脂综合征的患者的抗磷脂抗体相关血小板减少症或自身免疫性溶血性贫血:一项 6 年随访研究。
Blood. 2010 Oct 21;116(16):3058-63. doi: 10.1182/blood-2010-05-283507. Epub 2010 Jul 12.
5
Diagnosis and classification of the antiphospholipid syndrome.抗磷脂综合征的诊断和分类。
J Autoimmun. 2014 Feb-Mar;48-49:20-5. doi: 10.1016/j.jaut.2014.01.006. Epub 2014 Jan 24.
6
The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.多种抗磷脂抗体阳性在抗磷脂综合征患者中的新作用。
Expert Rev Clin Immunol. 2015;11(11):1255-63. doi: 10.1586/1744666X.2015.1080121. Epub 2015 Aug 20.
7
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.抗磷脂抗体 "标准" 检测:第 13 届国际抗磷脂抗体大会专题工作组及会前研讨会报告,德克萨斯州加尔维斯顿,2010 年 4 月。
Lupus. 2011 Feb;20(2):182-90. doi: 10.1177/0961203310395055.
8
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.血栓形成且抗磷脂三项阳性的抗磷脂综合征患者的治疗策略与妊娠结局:一项欧洲多中心回顾性研究
Thromb Haemost. 2014 Oct;112(4):727-35. doi: 10.1160/TH14-03-0191. Epub 2014 Jul 10.
9
The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.抗磷脂抗体 IgM 亚型在血管性抗磷脂综合征中的临床意义。
Thromb Res. 2015 Nov;136(5):883-6. doi: 10.1016/j.thromres.2015.08.019. Epub 2015 Sep 5.
10
What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?从患者和抗磷脂抗体携带者队列中,我们对抗磷脂综合征有了哪些了解?
Semin Thromb Hemost. 2012 Jun;38(4):322-7. doi: 10.1055/s-0032-1304719. Epub 2012 Mar 7.

引用本文的文献

1
Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseases.系统性红斑狼疮甲襞微血管镜检查参数的分布及其与疾病活动度的关联:一项代表欧洲抗风湿病联盟(EULAR)风湿病微循环研究小组开展的国际双盲病例对照分析
RMD Open. 2025 Sep 8;11(3):e005772. doi: 10.1136/rmdopen-2025-005772.
2
Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome.抗磷脂综合征的病理生理机制、临床表现及治疗方面的新进展。
Front Immunol. 2025 Aug 21;16:1639065. doi: 10.3389/fimmu.2025.1639065. eCollection 2025.
3
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications.
2023 年 ACR/EULAR 抗磷脂综合征分类标准确定了具有高并发症风险的患者。
Clin Rheumatol. 2024 Nov;43(11):3373-3377. doi: 10.1007/s10067-024-07144-7. Epub 2024 Sep 18.
4
Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.抗磷脂综合征与妊娠:新老发病机制。
Int J Mol Sci. 2023 Feb 6;24(4):3195. doi: 10.3390/ijms24043195.
5
A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome.对“黑天鹅”的简化理解:抗磷脂抗体综合征
JNMA J Nepal Med Assoc. 2019 Mar-Apr;57(216):133-145. doi: 10.31729/jnma.4226.
6
Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies.血浆因子 V 活性和凝血酶生成参数对血液病患者弥散性血管内凝血的诊断和预后价值。
Curr Med Sci. 2019 Aug;39(4):546-550. doi: 10.1007/s11596-019-2072-9. Epub 2019 Jul 25.
7
Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful?抗磷脂抗体综合征修订实验室分类标准的临床应用:12周而非6周的随访间隔是否具有显著效用?
Biomed Res Int. 2016;2016:2641526. doi: 10.1155/2016/2641526. Epub 2016 Aug 17.
8
Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation.弥散性血管内凝血中国新诊断评分系统的回顾性评估
PLoS One. 2015 Jun 15;10(6):e0129170. doi: 10.1371/journal.pone.0129170. eCollection 2015.